Journal Articles

Donald and Barbara Zucker School of Medicine
Academic Works

2018

Microarray analysis of human keratinocytes from
different anatomic sites reveals site-specific immune
signaling and responses to human papillomavirus
type 16 transfection
M. Israr
Northwell Health

D. Rosenthal
Zucker School of Medicine at Hofstra/Northwell

L. Frejo-Navarro
J. DeVoti
Northwell Health

C. Meyers
See next page for additional authors

Follow this and additional works at: https://academicworks.medicine.hofstra.edu/articles
Part of the Pediatrics Commons
Recommended Citation
Israr M, Rosenthal D, Frejo-Navarro L, DeVoti J, Meyers C, Bonagura VR. Microarray analysis of human keratinocytes from different
anatomic sites reveals site-specific immune signaling and responses to human papillomavirus type 16 transfection. . 2018 Jan 01;
24(1):Article 4694 [ p.]. Available from: https://academicworks.medicine.hofstra.edu/articles/4694. Free full text article.

This Article is brought to you for free and open access by Donald and Barbara Zucker School of Medicine Academic Works. It has been accepted for
inclusion in Journal Articles by an authorized administrator of Donald and Barbara Zucker School of Medicine Academic Works. For more
information, please contact academicworks@hofstra.edu.

Authors

M. Israr, D. Rosenthal, L. Frejo-Navarro, J. DeVoti, C. Meyers, and V. R. Bonagura

This article is available at Donald and Barbara Zucker School of Medicine Academic Works:
https://academicworks.medicine.hofstra.edu/articles/4694

Israr et al. Molecular Medicine (2018) 24:23
https://doi.org/10.1186/s10020-018-0022-9

RESEARCH ARTICLE

Molecular Medicine

Open Access

Microarray analysis of human keratinocytes
from different anatomic sites reveals
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type 16 transfection
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Abstract
Background: Stratified human keratinocytes (SHKs) are an essential part of mucosal innate immune response that
modulates adaptive immunity to microbes encountered in the environment. The importance of these SHKs in
mucosal integrity and development has been well characterized, however their regulatory immunologic role at
different mucosal sites, has not. In this study we compared the immune gene expression of SHKs from five different
anatomical sites before and after HPV16 transfection using microarray analyses.
Methods: Individual pools of human keratinocytes from foreskin, cervix, vagina, gingiva, and tonsils (HFKs, HCKs,
HVKs, HGKs and HTLKs) were prepared. Organotypic (raft) cultures were established for both normal and HPV16
immortalized HFKs, HCKs, HVKs, HGKs and HTLKs lines which stably maintained episomal HPV16 DNA. Microarray
analysis was carried out using the HumanHT-12 V4 gene chip (Illumina). Immune gene expression profiles were
obtained by global gene chip (GeneSifter) and Ingenuity pathway analysis (IPA) for each individual site, with or
without HPV16 transfection.
Results: We examined site specific innate immune response gene expression in SHKs from all five different
anatomical sites before and after HPV16 transfection. We observed marked differences in SHK immune gene
repertoires within and between mucosal tracts before HPV 16 infection. In addition, we observed additional
changes in SHKs immune gene repertoire patterns when these SHKs were productively transfected with HPV16.
Some immune response genes were similarly expressed by SHKs from different sites. However, there was also
variable expression of non-immune response genes, such as keratin genes, by the different SHKs.
Conclusions: Our results suggest that keratinocytes from different anatomical sites are likely hard wired in their
innate immune responses, and that these immune responses are unique depending on the anatomical site from
which the SHKs were derived. These observations may help explain why select HPV types predominate at different
mucosal sites, cause persistent infection at these sites, and on occasion, lead to HPV induced malignant and benign
tumor development.
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Background
Stratified human keratinocytes (SHKs) are important
immunologic components of both healthy and diseased
mucosal surfaces in addition to their established role as
physical epithelial barriers to infection. Accumulating
evidence shows that SHKs from various mucosal tracts
are important in mucosal development, inflammation,
and HPV-induced cancer development (Wu et al. 2011;
Saenz et al. 2008; Swamy et al. 2010; Nestle et al. 2009;
Strid et al. 2009). Responses of SHKs can cause immune
dysregulation (Swamy et al. 2010; Nestle et al. 2009;
Strid et al. 2009; Albanesi et al. 2005; Tonel and Conrad
2009), however they also support the maintenance of the
mucosal microbiome, via defensin expression, and they
preserve mucosal homeostasis (Chung and Dale 2004;
Frohm et al. 1997). Taken together, the importance of
SHKs in both innate and adaptive immunity at mucosal
sites is compelling (Swamy et al. 2010). Unresolved is
the mechanism(s) that render these cells resistant or
permissive to select viruses within a given viral family,
such as human papillomaviruses (HPVs).
Towards understanding how oral cavity-derived keratinocytes influence adaptive immunity, Wu et al. (Wu et al.
2011) performed a global gene expression analysis that
showed the significant effect of murine oral keratinocytes
on adaptive immunity (Wu et al. 2011).
We previously reported that human oral tissues are
permissive to HPV16 infection and that HPV replication
can spread via the oral cavity (Israr et al. 2016). Here we
compared the immune gene expression of SHKs using
microarray analyses of pooled human keratinocytes from
tonsil, foreskin, uterine cervix, vagina, and gingiva, before and after HPV16 transfection. We also compared
immune gene network expression by SHKs taken from
each of these anatomical sites to determine how they respond to HPV16 transfection. We observed marked differences in SHK immune gene expression within a given
mucosal tract and by those derived from different mucosal tracts. In addition, we observed additional changes in
SHK immune gene expression patterns when these
SHKs were productively transfected with HPV16.
Methods
SHKs cultures, generation of HPV16 positive cell lines

Individual pools of primary SHKs from foreskin, cervix,
vagina, gingiva, and tonsils (HFKs, HCKs, HVKs, HGKs
and HTLKs) were grown as previously reported
(McLaughlin-Drubin et al. 2004; McLaughlin-Drubin and
Meyers 2005). Organotypic (raft) cultures were established
as described (Meyers et al. 1997; McLaughlin-Drubin et
al. 2005). Each pool of SHKs was prepared from 3 to 5 individual healthy donors. Both normal and HPV16 immortalized HFKs, HCKs, HVKs, HGKs and HTLKs lines
which stably maintained episomal HPV16 DNA, and were
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seeded onto rat tail type 1 collagen matrices with J2 3 T3
feeder cells (Israr et al. 2016).
HPV16 infection of these SHKs could be more closely
analogous to a natural infection than transfection. However, HPV16 infection of keratinocytes results in low efficiency and high variability between cell lines. Second, cells
often lose more virus during further propagation (i.e.) in
raft cultures, while HPV16 transfection provides high
uptake efficiency, high cell line consistency, and rare heterogeneity. In addition, during transfection cells stably
maintain the HPV genome as an episome, which is a critical step for a productive HPV16 life cycle and persistent
HPV infection. Furthermore, integration of the HPV16
genome into keratinocyte DNA suppresses virus expression, and prevents formation of small, circular HPV16
genomes that can be packaged and transmitted to a new
host keratinocyte (McBride and Warburton 2017).
RNA isolation and microarrays analysis

Triplicate cultures, of each SHK pool were harvested,
and total RNA isolated using an RNeasy mini kit
(Qiagen). Microarray analysis was carried out using the
HumanHT-12 V4 gene chip (Illumina) containing 47231
probes targeting > 25,000 human genes. Expression data
(baseline + HPV infected for each site) was log transformed and normalized to the median. Initial comparisons
were performed using GeneSifter software and a volcano
plot constructed (p = 0.05). Genes with ≥ 2 fold expression
changes were considered significant in these analyses.
Comparison of gene expression by SHKs from different
mucosae

A list of “immunologic genes” was obtained by querying
http://ctdbase.org/ using key words “immu*, interleukin,
cytokine, and defensin”. Duplicates were removed,
resulting in 2576 unique genes. A search for these genes
in GeneSifter was done, sorted by expression using Kruskal-Wallis, (p cutoff = 0.02) resulting in 81 differentially
expressed genes. A principle component analysis (PCA)
was performed (dots = genes; lines with arrows = tissue
types; axis 3 principle components) and the tissue types
were separated using PC1, PC2, and PC3, to show differential gene expression patterns for these immunologic genes.
We then performed a pairwise analysis (normalized to
all medians, p-value cutoff< 0.05) comparing individual
SHKs from a single mucosal tract before and after
HPV16 transfection. Among all differentially expressed
genes (DEGs), a subset of genes known to be involved
in immune responses/associated with immune regulation was selected for analysis. Expression data was
analyzed using Ingenuity pathway analysis software:
(IPA®, QIAGEN Inc., https://www.qiagenbioinformatics.
com/products/ingenuitypathway-analysis). Networks were
generated using the Core analysis tool (Kramer et al. 2014).
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To better visualize the immunological genes
uniquely, and/or commonly expressed by SHKs from
each of the different anatomical sites, with or without
HPV transfection, we applied these data sets to software at http://bioinformatics.psb.ugent.be/webtools/Venn/
to generate a 5 intersection Venn/Euler diagram
(Fig. 2e) showing which DEGs were in expressed at
each intersection.

Results and discussion
Keratins and immune gene mRNA expression by SHKs
with or without HPV16 transfection

First we examined site specific keratins expression in all
five different anatomical sites with or without HPV16
transfection that is consistent with published reports
(Chu and Weiss 2002). As anticipated, all of the SHKs
expressed some of keratin genes, see Additional file 1:
Figure S1. However, there was variability in the repertoire of keratin genes that were expressed by different
SHKs, suggesting that the cultures of pooled primary
keratinocytes grown in rafts maintains the individual
gene expression profiles characteristic of the site(s) from
which the cells were obtained (Chu and Weiss 2002). As
expected, the majority of immune genes having significant levels of expression were expressed at similar levels
by all SHK cultures studied, see Fig. 2f. Significantly all 3
GAPDH probe sets, both HPRT-1 probe sets and all 3
B-actin probe sets were detected in all samples at equal
levels, as anticipated, since all expression data was normalized prior to analysis. In addition to several keratins
present in all tissue types (heat map), IFNAR1 and
IFNGR1 and IFNGR2 were detected at equivalent levels
in all samples tested, as well as IL-10 and the IL-10RB.
Also, both the IL-4R and the IL-13R were expressed by
all keratinocytes studied, and the expression of these
genes was unaffected by introducing HPV16.
Of note, expression of immune response genes varied
by site of SHK origin, see heat map and principal component analysis (Fig. 1a, b). Cluster analysis grouped gingival, vaginal and tonsil cells together, with the latter two
being more closely related. Foreskin and cervical cells
grouped together, but clearly showed many differences.
Within the upper digestive mucosal tract, gingival and
tonsil cells also showed differences, for example mRNA
expression for individual members of multiple classes of
immune genes (CCL-20, CXCL2 and CXCL6, interleukins IL-1, IL-8, and IL1F9 (IL-36γ)), and cell surface receptors/adhesion molecules (IL1RII, IL-13Rα, CD99).
Several defensins were expressed by SHKs from these
tissues, but not by cervical or foreskin SHKs.
We examined of all of the chemokines and interleukins
present on the gene microarray, and found a limited number of immunologic signaling molecules being expressed
in our keratinocyte cultures, largely irrespective of the
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derivation of the SHKs we studied. A single CCL chemokine, specifically CCL-20 was detected in all samples,
together with its receptor CCR6. 2 CXC chemokines,
CXCL14 and CXCL16 were also expressed by keratinocytes as well as the CXC receptors CXCR1 and CXCR7.
IL8 was also expressed by all keratinocytes studied, while
IL-23a was absent from both cervical and foreskin cultures. IL1-A and IL1-B were detected in all keratinocytes
studied, albeit at varying levels. However, the antagonist of
both 1A and 1B, IL1RN, the IL-20 receptor, and the
IL17D receptor were highly expressed by all keratinocytes
studied. IL-18 was equally expressed by all keratinocytes
studied. In contrast, the IL-1 family member IL1F9, now
called IL-36γ, and its antagonist IL1F5 were differentially
expressed by different keratinocytes obtained from different anatomical sites.
HPV16 transfected cells also showed marked differences between cell types (Fig. 1b). Under these conditions, (cut off significance = 0.02), 92 different genes
were identified. Similar to uninfected cells, vaginal and
tonsil cells clustered together. However, gingival cell immune gene expression was quite different, while foreskin
and cervical cells clustered together, although foreskin
and cervical SHKs were quite different from each other.
Among the most highly expressed genes by gingiva, vagina, and tonsil cells was IL-36γ. We previously reported
that this cytokine was highly expressed by laryngeal papilloma cells (HPV6/11 infected) (DeVoti et al. 2008;
DeVoti et al. 2014). Interestingly, IL36γ was not elevated
in HPV16+ foreskin and cervical cells. Thus, SHKs from
different mucosae show differential immune genes
expression before and after HPV transfection.
Comparing SHKs from different sites as a group before or after HPV transfection (Fig. 1c) showed that
SHKs before HPV16 transfection behaved more similarly
to each other than to their HPV16+ counterparts which
also behaved more similarly to each other (Fig. 1c). Two
exceptions were noted, HPV16+ SHKs from foreskin did
not express a similar repertoire of immune response
genes than HPV16+ cells from other anatomical sites
expressed, and HPV16− SHKs vaginal cells expressed
similar immune gene profiles as HPV+ cells from other
mucosae (Fig. 1c).
Immune gene mRNA networks expressed by SHKs from
different sites

We compared mRNA expression of an expanded list of
immune genes and regulators by Ingenuity software, at
each anatomical site with or without HPV16 transfection
(Fig. 2a-e). There were significant differences in gene pathways used by SHKs in response to HPV16 transfection at
each site. Differentially expressed genes in these comparisons are show in Additional file 2: Table S1. Fig. 2f
(Venn/Euler diagram) shows that there were more

Israr et al. Molecular Medicine (2018) 24:23

Page 4 of 7

Fig. 1 Immune gene mRNA repertoires of stratified human keratinocytes from different anatomical sites vary significantly. Results are for SHKs
grown in organotypic cultures from a pool of 3–5 individuals and represent 3 independent samples of each of the mucosal sites shown (baseline
and HPV infected). Data were log transformed, and normalized to the median. Eighty one “immunologic genes” are shown, and a principle
component analysis (PCA) performed (dots = genes; lines with arrows = tissue types; axis 3 PCA). Tissue types were separated (PC1, PC2, and PC3),
to demonstrate differential genetic expression patterns for these genes. Heat maps and the PCA for SHKs from each site are shown for resting
(a, d), HPV16 transfected (b, e), and HPV16− or HPV16+ keratinocytes from all sites separately grouped together (c, f)

differences in genes expressed by SHKs from each site,
compared to genes expressed in common by SHKs from
all sites.
In summary, immune gene expression by SHKs in
health and disease has previously been studied predominantly in the oral cavity (gingiva, tonsil), the skin, and the

uterine cervix (Wu et al. 2011; Chung and Dale 2004;
Frohm et al. 1997; Nees et al. 2001; Adami et al. 2014). In
some of these studies, mucosal biopsies from different epithelial tissues contained cells other than keratinocytes,
and they showed novel cytokine expression at different
anatomical sites (Frohm et al. 1997). However, there is
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Fig. 2 Immune gene network expression by HPV16+ stratified human keratinocytes from different anatomical sites vary significantly. Pairwise
analysis, normalized to all medians (p-value cutoff < 0.05) was performed individually to comparing SHKs expression at a single mucosal site
before and after HPV16 transfection. Differentially expressed genes were selected from a larger list of genes (immune responses/regulation) for
the analysis. Data were analyzed using Ingenuity pathway analysis software (IPA®, QIAGEN Inc., https://www.qiagenbioinformatics.com/products/
ingenuitypathway-analysis). Networks were generated using the Core analysis tool (a-e) (Kramer et al. 2014), and a Venn/Euler diagram was
generated (f) to visualize common vs. unique gene expression by applying the data sets of SHKs (different sites, resting vs HPV16+ cells) to
software at http://bioinformatics.psb.ugent.be/webtools/Venn/. The number of genes that were uniquely or commonly expressed by cells from
each anatomical site are shown within each intersection (f)
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only a single report of a genome wide analysis of oral
mucosa-derived SHKs in mice that demonstrated the essential role of these cells in regulating adaptive immunity
(Wu et al. 2011).
Several important points can be drawn from the results
presented in this communication. The repertoire of immune response genes expressed by resting SHKs from different mucosal tract show significant differences when
compared to each other (Fig. 1). These expression patterns
can distinguish one mucosa from another. Even within the
same mucosal tract there are marked differences in immune gene expression. These responses are likely to be
“hard wired” as SHKs from different sites do not regress to
express a common immune gene repertoire in organotypic
culture (Fig. 1). HPV16− SHKs from different anatomical
sites as a group cluster together and look more similar to
each other than do their HPV16+ counterparts, and vice
versa. However, there were a few notable exceptions
(Fig. 1c). We speculate that the mucosal immune
micromilieu at different anatomical sites may influence
which immune genes the keratinocytes express as it is
likely the stem cells that ultimately differentiate into
keratinocytes are the same for all keratinocytes at each
site. We have not performed microarrays of naturally
infected SHKs from these different anatomical sites,
however, our in vitro transfected cervical cell lines showed
similar gene expression profiles as previously published
in human HPV16 cervical cancers (Nees et al. 2001;
Santin et al. 2005; Perez-Plasencia et al. 2007).
Additionally, the immune gene repertoires of HPV16+
SHKs from different sites also differ from each other based
on the origin of the SHKs (Fig. 1b). Thus, immune gene
expression by these cells appears to also be based on
mucosal SHK origin (Fig. 1b). Finally, immune gene
networks associated with HPV16+ SHKs from the different
anatomical sites, compared to their HPV16 nontransfected counterparts, was not uniform and significantly
varied based on the anatomical origin of origin (Fig. 2a-f).
The significant variation in immune gene repertoires and
networks (Fig. 2f) may have bearing on why individual
members of the large HPV family of DNA viruses predominate as the cause of persistent infection and disease within
and between different mucosal tracts (Cubie 2013).

Page 6 of 7

are likely hard wired in their innate immune responses, before and after the introduction of HPV16, and that these
immune responses are unique depending on the anatomical
site from which they were derived.
The potential medical significance of understanding
and manipulating differential immunologic gene expression by keratinocytes from different mucosal anatomical
sites is intriguing. It is known that at some mucosal
sites, HPV 16 predominates as a potential pathogen and
causes persistent infection leading to malignancy, while
others, like HPV6 and 11 rarely if ever cause disease at
that mucosal site. For example, tonsil and base of
tongue, HPV-induced disease is caused by HPV16, but
not HPV6 or 11. In contrast, HPV 6 and 11 commonly
cause persist infection and “benign” respiratory papilloma development in the larynx and upper airway, while
HPV16 rarely does at this anatomical site. It is interesting to speculate that differential immune gene expression by keratinocytes from a given mucosal site may
convey resistance vs. susceptibility to different HPVs
dependent on the repertoire of innate immune responses
genes they express at a given mucosal site. This may be
so given that the keratinocyte HPV receptor appears to
be the same for all HPVs (Schafer et al. 2015; Raff et al.
2013). Thus, an explanation of why certain keratinocytes
from a given mucosal site are resistant to a some HPVs,
but susceptible to others, and vice versa for keratinocytes at different mucosal sites, may be related to the
kind of innate immune signaling that a given keratinocyte expresses at a given mucosal site, before and after
HPV infection. If this were the case, understanding how
keratinocytes confer resistance or susceptibility to a
given HPV at a given mucosal site could potentially
open a novel preventative and/or therapeutic modality
to block a specific HPV from causing persistent
infection, and ultimately benign or malignant tumor
development at a specificceptible anatomical site. These
observations may help explain why select HPV types
predominate at different mucosal sites, and can cause
persistent infection, that on occasion, can lead to HPV
induced malignancy.

Additional files
Conclusions
In this study, we identify the differences and similarities in
mRNA gene expression made by stratified keratinocytes obtained from five different anatomical sites, grown in organotypic cultures before and after HPV16 transduction. Our
results show that keratinocytes within and outside of a given
mucosal tract show different immune gene repertoires that
are site specific, and that introducing HPV16 into these cells
also alters their immune gene expression in a site specific
manner. Thus, keratinocytes from different anatomical sites

Additional file 1: Figure S1. Heat map showing the relative gene
expression level of keratins among five different stratified human
keratinocytes with or without HPV16 transfection. To generate a keratins
heat map. All keratin genes, KRT-1 to KRT-86 on the illumina human
HT-12v4 expression array were aligned and assigned colors corresponding
to the relative expression levels, comparing triplicate cultures of (Strid et al.
2009) types of normal human keratinocytes (NHK) with triplicate cultures
from each type transfected with HPV16. KRT-12, − 18, − 20, − 22, KRT-25
to KRT-77, KRT-79, and KRT-82 to KRT-86 were excluded because all 10
triplicates had average expression levels that were below the 95th percentile
of all genes on the chip. (XLSX 13 kb)
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Additional file 2: Table S1. Genes that are differentially expressed by
stratified human keratinocytes from different anatomical sites after HPV16
transfection. (DOCX 16 kb)
Abbreviations
DEGs: Differentially expressed genes; HCKs: Human cervical keratinocytes;
HFKs: Human foreskin keratinocytes; HGKs: Human gingival keratinocytes;
HPVs: Human papillomaviruses; HTLKs: Human tonsil keratinocytes;
HVKs: Human vaginal keratinocytes; IPA: Ingenuity pathway analysis;
PCA: Principle component analysis; SHKs: Stratified human keratinocytes
Acknowledgements
We thank Robert Brucklacher, Genome Sciences and Bioinformatics Core, Penn
State College of Medicine, Hershey for technical assistance in microarrays.
Funding
Research reported in this publication was supported by the National Institute
of Dental and Craniofacial Research (NIDCR) of the National Institutes of
Health under Award Numbers DE017227 to Vincent Bonagura and DE018305
to Craig Meyers.
Availability of data and materials
The datasets used and/or analysed during the current study are available
from the corresponding author on reasonable request.
Authors’ contributions
MI performed the cell and organotypic cultures and microarrays in Dr. Meyers
laboratory before moving to Dr. Bonagura laboratory, DR performed the heat
map and principal component data analysis, LF-N performed the Ingenuity
analysis. CM conceptualized and supported Dr. Israr’s efforts to generate
keratinocyte organotypic cultures, and the HPV16 transfection and microarray
experiments. VRB conceptualized and supported the experiments that analyzed
keratinocyte immune gene expression in the keratinocyte microarray
experiments. All authors read and approved the final manuscript.
Ethics approval and consent to participate
This research falls under Northwell Health IRB protocol 13-526B approval date
July 7, 2017, expiration date July 6, 2018. Tissue discarded research not
involving greater than minimal risk.
Competing interests
The authors declare they have no competing interests as defined by
Molecular Medicine, or other interests that might be perceived to influence
the results and discussion reported in this paper.

Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Author details
1
The Feinstein Institute for Medical Research, Manhasset, NY, USA; Division of
Allergy and Immunology, Department of Pediatrics, Donald and Barbara
Zucker School of Medicine at Hofstra/Northwell, Great Neck, NY, USA.
2
Department of Genomic Medicine, Otology and Neurotology Group CTS495,
Centre for Genomics and Oncological Research, Pfizer/Universidad de
Granada/Junta de Andalucía (GENYO), Granada, Spain. 3Department of
Microbiology and Immunology, The Pennsylvania State University College of
Medicine, Hershey, PA, USA.
Received: 16 January 2018 Accepted: 24 April 2018

References
Adami GR, et al. Gene expression based evidence of innate immune response
activation in the epithelium with oral lichen planus. Arch Oral Biol.
2014;59:354–61.
Albanesi C, Scarponi C, Giustizieri ML, Girolomoni G. Keratinocytes in inflammatory
skin diseases. Curr Drug Targets Inflamm Allergy. 2005;4:329–34.
Chu PG, Weiss LM. Keratin expression in human tissues and neoplasms.
Histopathology. 2002;40:403–39.

Page 7 of 7

Chung WO, Dale BA. Innate immune response of oral and foreskin keratinocytes:
utilization of different signaling pathways by various bacterial species.
Infect Immun. 2004;72:352–8.
Cubie HA. Diseases associated with human papillomavirus infection. Virology.
2013;445:21–34.
DeVoti JA, et al. Immune dysregulation and tumor-associated gene changes in
recurrent respiratory papillomatosis: a paired microarray analysis. Mol Med.
2008;14:608–17.
DeVoti JA, et al. Decreased Langerhans cell responses to IL-36gamma: altered
innate immunity in patients with recurrent respiratory papillomatosis.
Mol Med. 2014;20:372–80.
Frohm M, et al. The expression of the gene coding for the antibacterial peptide
LL-37 is induced in human keratinocytes during inflammatory disorders.
J Biol Chem. 1997;272:15258–63.
Israr M, Biryukov J, Ryndock EJ, Alam S, Meyers C. Comparison of human
papillomavirus type 16 replication in tonsil and foreskin epithelia. Virology.
2016;499:82–90.
Kramer A, Green J, Pollard J, Tugendreich S Jr. Causal analysis approaches in
ingenuity pathway analysis. Bioinformatics. 2014;30:523–30.
McBride AA, Warburton A. The role of integration in oncogenic progression of
HPV-associated cancers. PLoS Pathog. 2017;13(4):e1006211.
McLaughlin-Drubin ME, Bromberg-White JL, Meyers C. The role of the human
papillomavirus type 18 E7 oncoprotein during the complete viral life cycle.
Virology. 2005;338:61–8.
McLaughlin-Drubin ME, Christensen ND, Meyers C. Propagation, infection, and
neutralization of authentic HPV16 virus. Virology. 2004;322:213–9.
McLaughlin-Drubin ME, Meyers C. Propagation of infectious, high-risk HPV in
organotypic “raft” culture. Methods Mol Med. 2005;119:171–86.
Meyers C, Mayer TJ, Ozbun MA. Synthesis of infectious human papillomavirus
type 18 in differentiating epithelium transfected with viral DNA. J Virol.
1997;71:7381–6.
Nees M, et al. Papillomavirus type 16 oncogenes downregulate expression of
interferon-responsive genes and upregulate proliferation-associated and
NF-kappaB-responsive genes in cervical keratinocytes. J Virol. 2001;75:4283–96.
Nestle FO, Di Meglio P, Qin JZ, Nickoloff BJ. Skin immune sentinels in health and
disease. Nat Rev Immunol. 2009;9:679–91.
Perez-Plasencia C, et al. Genome wide expression analysis in HPV16 cervical
cancer: identification of altered metabolic pathways. Infect Agent Cancer.
2007;2:16.
Raff AB, et al. The evolving field of human papillomavirus receptor research: a
review of binding and entry. J Virol. 2013;87:6062–72.
Saenz SA, Taylor BC, Artis D. Welcome to the neighborhood: epithelial cell-derived
cytokines license innate and adaptive immune responses at mucosal sites.
Immunol Rev. 2008;226:172–90.
Santin AD, et al. Gene expression profiles of primary HPV16- and HPV18-infected
early stage cervical cancers and normal cervical epithelium: identification of
novel candidate molecular markers for cervical cancer diagnosis and therapy.
Virology. 2005;331:269–91.
Schafer G, Blumenthal MJ, Katz AA. Interaction of human tumor viruses with host
cell surface receptors and cell entry. Viruses. 2015;7:2592–617.
Strid J, Tigelaar RE, Hayday AC. Skin immune surveillance by T cells–a new order?
Semin Immunol. 2009;21:110–20.
Swamy M, Jamora C, Havran W, Hayday A. Epithelial decision makers: in search of
the ‘epimmunome’. Nat Immunol. 2010;11:656–65.
Tonel G, Conrad C. Interplay between keratinocytes and immune cells–recent
insights into psoriasis pathogenesis. Int J Biochem Cell Biol. 2009;41:963–8.
Wu T, et al. Genome-wide analysis reveals the active roles of keratinocytes in
oral mucosal adaptive immune response. Exp Biol Med (Maywood).
2011;236:832–43.

